Advancing neuroprotection and atherosclerosis prevention through familial hypercholesterolemia management: Analyzing comorbidity burden with stroke, coronary heart disease, hypertension, and diabetes

With a large number of patients with dyslipidemia, the type and number of comorbidities significantly impact the healthcare burden. FH presents with earlier onset, more comorbidities, and heavier cardiovascular-related medical burdens than HC. Early identification, intervention, and comprehensive management of comorbidities in the FH population are crucial for neuroprotection and prevention of atherosclerotic cardiovascular disease.

Authors

Institutions

Publication Details

Journal
Neuroprotection/Neuroprotection (Chichester, England. Print)
Published
2025-02-12
DOI
https://doi.org/10.1002/nep3.72
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advancing neuroprotection and atherosclerosis prevention through familial hypercholesterolemia management: Analyzing comorbidity burden with stroke, coronary heart disease, hypertension, and diabetes

Jingjia Wang, Xuliang Wang, Jun Gao, Zhiyun Yang et al.
Neuroprotection/Neuroprotection (Chichester, England. Print)
Lipoproteins and Cardiovascular Health
article

Advancing neuroprotection and atherosclerosis prevention through familial hypercholesterolemia management: Analyzing comorbidity burden with stroke, coronary heart disease, hypertension, and diabetes

Jingjia Wang, Xuliang Wang, Jun Gao, Zhiyun Yang, Pei Gao, Siyan Zhan, Jilin Zheng, Wei Chen, Da Liu, Jun Wen, Sicong Liu, Ming Zhang, Lin Yang, Xiangbin Meng, Chunli Shao, Wenyao Wang
article en

Abstract

With a large number of patients with dyslipidemia, the type and number of comorbidities significantly impact the healthcare burden. FH presents with earlier onset, more comorbidities, and heavier cardiovascular-related medical burdens than HC. Early identification, intervention, and comprehensive management of comorbidities in the FH population are crucial for neuroprotection and prevention of atherosclerotic cardiovascular disease.

Neuroprotection/Neuroprotection (Chichester, England. Print)Vol. 3(1)
Hebei Medical University (CN), Chinese Academy of Sciences (CN), Peking University (CN), SGIDI Engineering Consulting (China) (CN), Academy of Mathematics and Systems Science (CN), Peng Cheng Laboratory (CN), Peking University Third Hospital (CN), Beijing Chuiyangliu Hospital (CN), First Affiliated Hospital of Hebei Medical University (CN), Tianjin Medical University (CN)
National Natural Science Foundation of China, Peking University
Openalex Percentile: Top 96%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.